A Study of DER 45-EV Gel to Treat Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

January 31, 2013

Conditions
Rosacea
Interventions
DRUG

DER 45 EV

Topical application to face for 12 weeks

DRUG

Vehicle

Topical application to face for 12 weeks

Trial Locations (10)

14623

Skin Search of Rochester, Inc, Rochester

30909

Augusta Centre for Dermatology and Skin, Augusta

33140

Baumann Cosmetic & Research Institute, Miami

33175

FXM Research Corp, Miami

37215

Tennessee Clinical Research Center, Nashville

53719

Madison Skin and Research, Inc, Madison

55432

Minnesota Clinical Study Center, Fridley

77840

J & S Studies, Inc, College Station

78759

DermResearch, Inc, Austin

99204

Premier Clinical Research, Spokane

All Listed Sponsors
lead

Sol-Gel Technologies, Ltd.

INDUSTRY

NCT00940992 - A Study of DER 45-EV Gel to Treat Rosacea | Biotech Hunter | Biotech Hunter